Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1517

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1517.)
© 1998 American Heart Association, Inc.


In Memoriam

Jeffrey M. Hoeg


Dr Jeffrey M. Hoeg died July 21, 1998, following a short, courageous battle with renal cancer. Jeff's death at the young age of 46 was a terrible loss to his colleagues and to the fields of hyperlipidemia and cardiovascular disease. Jeff was a remarkable physician-scientist with a charismatic personality, an infectious smile, and a wonderful sense of humor. He thoroughly enjoyed life and was a joy to be around. Each of us benefited from Jeff's warmth, enthusiasm, and positive attitude. Jeff was a superb role model, both as a physician-scientist and mentor, as well as a friend of young investigators. He guided each young scientist with great care and insight as their careers blossomed under his tutelage. In addition to being an outstanding investigator, Jeff was an excellent physician and was loved by his patients. He had a particular interest in children with familial hypercholesterolemia and played a central role in the development of new and innovative treatment programs for these patients with very high cholesterol levels. Jeff was internationally known for the treatment of familial hypercholesterolemia and patients were referred to his care from around the world.

Jeff made several significant contributions to both basic and clinical research in the fields of lipoproteins and cardiovascular disease. Of particular importance was the challenging development of transgenic rabbits as a model system for the study of lipoprotein metabolism and atherosclerosis. The generation of the transgenic rabbit as a useful animal model is Jeff's legacy to the field of cardiovascular disease.

Jeff . . . [Full Text of this Article]